MRPL1 and neoplasm: By contrast, the tumor volumes in the neoantigen-pulsed DC vaccine groups were as follows: 736 ± 243 mm3 in the MUT-Mtmr10 group, 791 ± 574 mm3 in the MUT-Elfn2 group, 559 ± 515 mm3 in the MUT-Kat8 group, 432 ± 422 mm3 in the MUT-Mastl group, 828 ± 837 mm3 in the MUT-Zscan21 group, and 1049 ± 1013 mm3 in the MUT-Mrpl1 group.